Stockscreener 앱 받기
2.26
0.00%
0.00
시간 외 거래:
2.26
Senti Biosciences Inc 주식(SNTI)의 최신 뉴스
Institutional owners may take dramatic actions as Semler Scientific, Inc.'s (NASDAQ:SMLR) recent 10% drop adds to one-year losses - Simply Wall St
Biotech Soars On Material Transfer Agreement - Invezz
Nasdaq Composite (NASX) QuotePress Release - The Globe and Mail
Sensata Technologies Holding plc (NYSE:ST) Stake Decreased by Shapiro Capital Management LLC - Defense World
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World
Granite Investment Partners LLC Increases Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Critical Analysis: UL Solutions (NYSE:ULS) & NeoGenomics (NASDAQ:NEO) - Defense World
Daiwa Securities Group Inc. Purchases Shares of 545 Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Semler Scientific Inc (SMLR) Shares Gap Down to $24.43 on Sep 18 - GuruFocus.com
SanBio’s Q2 Financials and Regenerative Medicine Push - TipRanks
After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com Australia
After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Federated Hermes Inc. Raises Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - MarketBeat
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024 - MSN
Senti Bio to Participate in Upcoming Investor Conferences - Yahoo Finance UK
Senti Bio to Participate in Upcoming Investor Conferences - Marketscreener.com
Senti Bio to Participate in Upcoming Investor Conferences - Yahoo Finance
Senti Bio to Participate in Upcoming Investor Conferences - StockTitan
Senti Biosciences (NASDAQ:SNTI) Trading Up 5.2% - MarketBeat
Biopharma Layoff Tracker 2024: Lykos, Galera, Grail and More Cut Staff - BioSpace
SNTISenti Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024 - InvestorPlace
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights - BioSpace
Intel Dumps All Of Its Shares In Arm Holdings, Still Retains Exposure To Astera Labs, Joby Aviation, MariaDB, And Senti Biosciences - Wccftech
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights - Marketscreener.com
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights - StockTitan
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights - ForexTV.com
Titan Pharmaceuticals (NASDAQ:TTNP) vs. Senti Biosciences (NASDAQ:SNTI) Critical Contrast - Defense World
A Deep Dive into Senti Biosciences Inc. (SNTI) Stock Performance - The InvestChronicle
Financial Health Report: Senti Biosciences Inc. (SNTI)’s Ratios Tell a Tale - The Dwinnex
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202 - ForexTV.com
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202 - Marketscreener.com
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202 - StockTitan
Senti Bio announces execution of grant award from CIRM for developing SENTI-202 - TipRanks
Senti Biosciences announces 1-for-10 reverse stock split - Investing.com India
Senti Biosciences announces 1-for-10 reverse stock split By Investing.com - Investing.com Canada
Senti Biosciences announces 1-for-10 reverse stock split - Investing.com
Senti Biosciences Inc. (SNTI)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Senti Biosciences amends equity facility agreement - Investing.com
Senti Bio executes reverse stock split to meet Nasdaq requirements - Investing.com
Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance - Seeking Alpha
Senti Bio Announces Reverse Stock Split - Yahoo Finance
Senti Biosciences (NASDAQ:SNTI) Trading Down 2.1% - Defense World
There is no way Senti Biosciences Inc. (SNTI) can keep these numbers up - SETE News
Examining Senti Biosciences Inc. (SNTI) stock is warranted - US Post News
Daily Market Movement: Senti Biosciences Inc. (SNTI) Sees a -20.51 Decrease, Closing at 0.31 – DWinneX - The Dwinnex
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAutonomix Medical (NASDAQ:AMIX), Absci ... - Benzinga
Views of Wall Street's Leading Experts on Senti Biosciences Inc. – Sete News - SETE News
Senti Biosciences (NASDAQ: SNTI) Stock Skyrockets on $8 Million Grant Award - ABBO News
Actions for Diversifying Your Penny Stocks Portfolio in 2024 - PennyStocks
why Senti Biosciences Inc. [SNTI] is a Good Choice for Investors After New Price Target of $2.00 – The DBT News - The DBT News
Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks - MarketBeat
RA Capital Management buys $49.95m of Eliem Therapeutics stock By Investing.com - Investing.com Canada
SNTI’s Stochastic Averages Dip: Analyzing Senti Biosciences Inc.’s Stock Performance - The InvestChronicle
Senti Biosciences awarded $8 million for cancer trial By Investing.com - Investing.com India
Senti Biosciences awarded $8 million for cancer trial By Investing.com - Investing.com
Senti Biosciences (SNTI) Secures $8 Million Grant to Advance Groundbreaking Cancer Treatment - BP Journal
Senti Biosciences awarded $8 million for cancer trial By Investing.com - Investing.com UK
Senti Bio (NASDAQ: SNTI) Gains Ground - All Finance Times
Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening? - Benzinga
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic ... - StockTitan
0.05%
4.86%
자본화:
|
볼륨(24시간):